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The management of facial defects has rapidly changed in the last decade. Functional and esthetic requirements have 
steadily increased along with the refinements of surgery. In the case of advanced atrophy or jaw defects, extensive 
horizontal and vertical bone augmentation is often unavoidable to enable patients to be fitted with implants. Loss 
of vertical alveolar bone height is the most common cause for a non primary stability of dental implants in adults. 
At present, there is no ideal therapeutic approach to cure loss of vertical alveolar bone height and achieve optimal 
pre-implantological bone regeneration before dental implant placement. Recently, it has been found that specific pop-
ulations of stem cells and/or progenitor cells could be isolated from different dental resources, namely the dental fol-
licle, the dental pulp and the periodontal ligament. Our research group has cultured palatal-derived stem cells (paldSCs) 
as dentospheres and further differentiated into various cells of the neuronal and osteogenic lineage, thereby demonstrat-
ing their stem cell state. In this publication will be shown whether paldSCs could be differentiated into the osteogenic 
lineage and, if so, whether these cells are able to regenerate alveolar bone tissue in vivo in an athymic rat model. 
Furthermore, using these data we have started a proof of principle clinical- and histological controlled study using 
stem cell-rich palatal tissues for improving the vertical alveolar bone augmentation in critical size defects. The initial 
results of the study demonstrate the feasibility of using stem cell-mediated tissue engineering to treat alveolar bone 
defects in humans.
Keywords: Human palatal-derived stem cells (paldSCs), Osteogenic differentiation, Athymic immunodeficient rats, Stem-cell 
enriched palatal-derived tissues, Proof of principle clinical-and histologically-con, Osteoplastic surgical methods
Introduction 
The management of facial defects has rapidly changed 
in the last decade. Functional and esthetic requirements 
have steadily increased along with the refinements of 
surgery. Facial defects include nearly all aspects of the 
face, i.e. the facial soft tissues, skull, and teeth. Disfigur-
ement and extension of a defect go inparallel; seen in 
clefts, Noma, which is a devastating gangreneous disease 
that leads to severe tissue destruction of the face and 
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long-lasting defects after trauma and tumour surgery.
The fact that speaking, mastication, deglutition, and ef-
fortless respiration are localized in the face, dictates the 
goal for any treatment: the most lifelike restoration possi-
ble to restore physiological function. To date the most fre-
quently used technique for reconstruction of extended de-
fects is the transfer of vascularized osseous respectively os-
seo(-myo-)cutaneous free flaps in particular as part of on-
cologic surgery of the head and neck region. Fibula, scap-
ula, and iliac crest were the preferred donor sites (Vinzenz 
and C. Schaudy, 2011).
In the case of advanced atrophy or jaw defects, ex-
tensive horizontal and vertical bone augmentation is often 
unavoidable to enable patients to be fitted with implants. 
These implantological procedures are usually two-stage. 
Bone block transplantation is a good model to evaluate 
bone regeneration. It is common to combine autologous 
bone blocks with alloplastic material. Drawback of the 
procedure is that, to obtain autologous bone, an additional 
surgical step is needed, causing donor-site morbidity 
(Grimm et al. 2012, 2013). If alloplastic materials are used 
without addition, normally longer healing times are chos-
en to compensate for the initial lack of regeneration. This 
explains why there are minor reports about healing peri-
ods of less than 6 months when pure allogenic material 
is used. The report of our research group (Plöger and 
Schau, 2010) has showed in the first time the healing peri-
ods of more than three years when pure allogenic material 
is used.
The regeneration of bone requires an adequate scaffold 
as well as cells that are capable to attach to the scaffold, 
proliferate, and differentiate. The dynamics of bone heal-
ing are controlled by growth factors, such as bone morpho-
genetic proteins. To promote these requirements, several 
strategies for bone and tissue regeneration have been 
developed.
The discovery of stem cells and recent advances in cel-
lular and molecular biology has led to the development 
of novel therapeutic strategies that aim at the regeneration 
of many tissues that were injured by disease. Tissue en-
gineering is a multidisciplinary field that combines biol-
ogy, engineering, and clinical science with the goal of gen-
erating new tissues and organs. It is a science based on 
fundamental principles that involves the identification of 
appropriate cells, the development of scaffolds and mor-
phogenic signals required to induce cells to regenerate a 
tissue or organ.
Neural crest cells could be termed a dormant stem cell 
population in the adult, as they are pluripotent at first, 
but with migration they become restricted during develop-
ment (Cheng et al. 2012). Neural crest cells that form the 
vertebrate head skeleton migrate and interact with sur-
rounding tissues to shape the skull. In common with most 
organs, teeth develop from interactions between epithelial 
cells (oral epithelium) and mesenchymal cells (cranial 
neural-crest-derived ectomesenchyme).
From a biological perspective, current and future pros-
pects for improved regeneration of bone in the facial skull 
and upper and lower jaw are dependent on the ability to 
facilitate the repopulation of the wound by cells capable 
of promoting regeneration.
Several recent studies showed that neural crest-related 
stem cells can be isolated from mammalian craniofacial 
tissues such as periodontal ligament, dental pulp, and 
palate. These cells have in common that they form neuro-
sphere-like clusters and proliferate in serum-free culture 
in the presence of fibroblast growth factor-2 (FGF-2) and 
epidermal growth factor (EGF).
From this perspective, the human palate has been 
shown to be of critical importance in the regenerative 
process. Although it is clear that cells residing in the sub-
epithelial soft tissue of the palate can achieve bone re-
generation, this population is heterogenous (Harris, 1999), 
but it is not known which subpopulations are capable of 
achieving regeneration. Indeed, cells derived from palate 
were found to have specific properties, such as increased 
proliferation rates, and representative of a regenerative 
phenotype as shown by research group (Greiner et al. 
2011, Widera et al. 2009).
In order to understand the cellular origins of Neural 
Crest Stem Cells from Dental and Periodontal Tissues, 
transplanted tooth buds were used to show that the mesen-
chymal-derived dental follicle surrounding the developing 
tooth root is the source of progenitor cells for cementum, 
alveolar bone and periodontal ligament (Heinemann and 
Götz 2013). Further evidence, that cells from the dental 
follicle are precursors to cementoblasts and to osteoblasts, 
has been shown by direct cell migration in the rat molars. 
More recently, the dental follicle associated with third mo-
lars has been shown to contain precursor cells which are 
clonogenic and have the ability to differentiate under in 
vitro conditions to a membrane-like structure containing 
calcified nodules (Morsczeck et al. 2009). 
The source of post-natal progenitor cells which may be 
capable of regenerating the alveolar bone has been inves-
tigated for a number of years. Cell kinetic experiments in 
mice and rats have shown that osteoblast populations of 
the subepithelial palatal soft tissue represent a steady-state 
renewal system, with the number of new cells generated 
by mitosis equal to the number of cells lost through apop-
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Fig. 1. SEM: Cultured palatal-derived stem cells (paldSC) form 
spheres.
tosis and migration. This capacity for self-renewal, which 
is further evidenced by the rapid turnover of these stem 
cells, supports the notion of progenitor/stem cell popu-
lations. Furthermore, a significant number of pala-
tal-derived stem cells do not enter the cell cycle, suggest-
ing that these cells may act in a similar manner to quies-
cent, self-renewable and multipotent stem cells.
The relationship between progenitor cells in regenerat-
ing tissues and normally functioning (steady-state) tissues 
has been investigated in studies performed in normal 
mouse alveolar bone, wounded mouse alveolar bone de-
fects, normal rat gingiva and inflamed monkey gingiva 
(see overview by Mao et al.). These studies have identified 
a common paravascular location for osteo- and fibroblast 
progenitors. These cells exhibit some of the classical cyto-
logical features of stem cells, including small size, re-
sponsiveness to stimulating factors, and slow cycle time 
(Schomann et al. 2013). Furthermore, these paravascular 
cells exhibit spatial clustering which suggests a possible 
clonal distribution of progenitors and their progeny 
(Vertelov et al. 2013).
Other possible sources of osteoblast and cementoblast 
precursors are the endosteal spaces of alveolar bone from 
which cells have been observed to adopt a paravascular lo-
cation in the bone of mice (Marx and Tursun 2011). 
Through a combination of transplanted biomaterials 
containing appropriately selected and primed stem cells, 
together with an appropriate mix of regulatory factors and 
extracellular matrix components to allow growth and spe-
cialization of the cells, the research of new therapies with 
significant clinical potential in alveolar bone surgery and 
facial skull surgery are emerging (Bartold et al. 2000). 
Neural Crest Stem Cells from Dental and 
Periodontal Tissues
Innovative therapeutic concept
Our innovation describes a new and previously over-
looked way to prepare the endogenous repairing stem cells 
on the basis of their ecto-mesenchymal like phenotype 
(Molthera; PCT/EP2006/066221). Our new cell therapeutic 
product is already developed on a research laboratory 
scale. The patient-specific adult stem cells can be easily 
isolated and propagated without human serum (serum- 
free medium) from the oral cavity.
Thus neural crest cells might be the endogenous repair 
troop, which is also in the right differentiation stage to 
regenerate multi-lineage tissues. Generally, most organs 
including teeth develop from interactions between epi-
thelial cells (oral epithelium) and mesenchymal cells 
(cranial neural-crest-derived ectomesenchyme).
Several recent studies showed that neural crest-related 
stem cells can be isolated from mammalian craniofacial 
tissues (Fig. 1) such as periodontal ligament and from hu-
man palate as shown by our research group (Widera et 
al. 2007, 2009, Molnar et al. 2008) and by Techawattan-
awisal et al. (2007) or dental pulp as shown by our inter-
national research group (Kiraly et al. 2009).
These cells have in common that they form neuro-
sphere-like clusters and proliferate in serum-free culture 
in the presence of fibroblast growth factor-2 (FGF-2) and 
epidermal growth factor (EGF). In light of these findings, 
the reason for this consortium is the identification of stem 
cells within the human palate. Palate is a highly re-
generative and richly innervated craniofacial tissue. It is 
well described that wounds within oral mucosa heal 
rapidly. This capability for rapid regeneration may be ex-
plained either by the presence of growth factors, such as 
basic fibroblast growth factor in the saliva, or by the poten-
tial presence of at least one stem cell type within the tissue.
To decipher the developmental make-up of the alveolar 
and facial bone region, we will follow the path of the mi-
gratory neural crest, the neural crest lineage segregation 
as a blueprint for bone regeneration since it gives rise to 
bone progenitor tissues, which in turn are subjected to the 
influence of diverse bone extracellular matrices and pep-
tide growth factors. We propose that the developmental 
history of a tissue is a highly instructive design template 
for the discovery of novel bioengineering tools and ap-
proaches (Kharazi et al. 2013). Further developments will 
include a formulation for clinical applications. This for-
mulation will be based on scaffolds or delivery systems, 
which will be developed during this application. This will 
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lead to the therapy of previously untreatable cases of facial 
defects and of advanced alveolar bone loss.
Purpose 
Several tissue engineering approaches have been tried 
to stimulate bone formation. The addition of in vitro cul-
tured mesenchymal stem cells (MSCs) has proven to stim-
ulate osteogenesis. Preclinical and clinical studies have 
demonstrated the ability of bone marrow-derived stem and 
progenitor cells to regenerate various tissues, including 
bone (Marx et al. 2012). To bypass the problem of se-
lection, multiplication, and differentiation, most of the 
mentioned studies selected MSCs, multiplied them, and 
then differentiated them to the osteogenic lineage. As this 
is unreasonable to do in daily practice, in this “proof of 
principle” clinical-controlled study approach was chosen in 
which allogenic bone blocks will be combined with pala-
tal-derived stem cells (paldSCs, see purpose).
Based on the hypothesis that the number of paldSCs is 
secondary, the individual potential of paldSCs to survive 
high stress and chemotactically attract osteogenic progeni-
tor cells will dominate. As the augmentation material is 
far from local blood supply, it can be assumed that a natu-
ral selection procedure will be applied to the cells. As 
blood and oxygen supply are reestablished, the paldSCs 
could then unfold their full potential.
During the physiological bone healing, osteoprogenitor 
cells migrate into the defect, differentiate into osteoblasts, 
and produce calcified matrix. These osteoprogenitor cells 
derive from multipotent ecto-mesenchymal palatal-derived 
stem cells (paldSCs) that are recruited from palate. 
PaldSCs can tolerate low oxygen concentrations and have 
the potential for osteogenic, chondrogenic, and adipogenic 
differentiation, depending on the external stimulus by 
cytokines. To stimulate bone healing, various grafting 
techniques have been developed to supply additionally ei-
ther cytokines, progenitor cells, suitable scaffolds, or any 
combination of them. In our study design we propose add-
ing EMDOGAIN®. EMDOGAIN® can increase bone for-
mation dynamics.  
The purpose of this study is to evaluate the potential 
of Adult Palatinum as a Novel source of stem cells in com-
bination with transplantation of OsteoGraft Spongiosa/ 
Corticalis Bonering Blocks (maxgraft® bonering, botiss bi-
omaterials, Germany) for one-stage bone augmentation 
and immediatly implant placement. These combination of 
methods for vertical augmentation in difficult anatomical 
sites will be tested in in a multicentric, “proof of principle” 
randomized, controlled, clinical, radiological and, histo-
logical trial.
Our group gained clinical experience with the bone 
block technique and isolation, cultivation, and character-
ization of palatinal-derived stem cells (paldSCs). Based on 
this key discovery we aim to develop a regenerative cell 
therapy.
Characterization of paldSCs by RT-PCR and flow cy-
tometry revealed expression of several stem cell markers, 
such as nestin and Sox2 as well as STRO-1 and CD146. 
In 2007 our research group first describe the character-
ization and neuronal differentiation capacity of stem cells 
derived from inflamed periodontal tissues (Widera et al., 
2007a). These so called periodontal-derived stem cells 
(pdSCs) were isolated by minimally invasive periodontal 
surgery and cultured as so-called dentaspheres under se-
rum-free conditions in the presence of FGF-2 and EGF.
Differentiation studies revealed that paldSCs exhibit an 
osteogenic differentiation capacity. The osteogenic differ-
entiation capacity of paldSCs was markedly developed 
suggesting that these cells might be a suitable cellular tool 
for bone regeneration purposes (Widera et al. 2007b).
Cultivation of paldSCs in neuronal differentiation me-
dia indicated the high neuronal differentiation capacity of 
these stem cells from periodontal tissue. Cells adopted a 
neuronal morphology and expressed a variety of neuronal 
markers, such as β-III-tubulin, Map2, GAD67, neurofila-
ment-L (NF-L), neurofilament-M (NF-M), neurofilament-H 
(NF-H), and synaptophysion (results not shown).
Thus, we looked for a novel source of stem cells from 
the oral cavity being higly suited for regenerative 
purposes. In 2009 Widera et al. described for the first time 
the presence of nestin-positive neural crest-related stem 
cells within Meissner corpuscles and Merkel cell-neurite 
complexes located in the hard palate of adult Wistar rats. 
These cells were characterized by expression of nestin, the 
transcription factor Sox2, and additional neural crest 
markers such as Slug or Snail.
To prove for the putative bone regeneration capacity of 
paldSCs in an in vivo (Grimm et al. 2011) experimental 
setting an athymic rat model was conducted (Fig. 2). The 
current study demonstrates that isolating paldSCs from 
patients undergoing open flap minimally invasive perio-
dontal surgery seems to be a simple and reliable method. 
These cells can be easily propagated ex vivo, thereby still 
preserving their stem cell state. As demonstrated pre-
viously and shown here, paldSCs are capable to differ-
entiate both into the neuronal lineage as well as the osteo-
genic lineage. In vivo studies clearly showed that human 
adult pdSCs being transplanted into an athymic rat model 
were able to regenerate periodontal tissue elements at dif-
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Fig. 2. Experimental setting on an athymic rat model.
Fig. 3. Allogen human bone rings (maxgraftⓇ bonering, botiss bio-
materials, Germany) with preserved biomechanical properties: 
Sterile without antigenic effects, Storable at room temperature for 
5 years, Osteoconductive properties supporting natural and con-
trolled tissue remodeling.
ferent levels. 
Case presentation (proof of principle study) and 
Protocol specifications
The clinical study has been approved by the ethics com-
mittees of the Zahnärztekammer Westfalen/Lippe and the 
University of Münster (Germany).
The study will be conducted in accordance with the 
Declaration of Helsinki (Fifth Revision, 2004). Patients 
older than 18 years with need of dental implant placement 
will be eligible if they had a maximum of 4 mm residual 
alveolar height. They had to be able to comply with 
study-related procedures, such as returning for follow- up 
examinations, exercising good oral hygiene, and being 
able to understand the nature of the proposed surgery. 
Written informed consent will be obtained prior to any 
study-related procedures. Exclusion criteria will be smok-
ing, history, signs of malignancy, radiotherapy or chemo-
therapy, pregnancy or nursing, general contraindications 
for dental or surgical treatment, medications, treatments 
or diseases, which may have an effect on bone remodeling, 
bone or connective tissue metabolism, or an allergy to 
collagen. 
The patients included in the study will be divided into 
three groups: 
ㆍpatients belonging to only test or comparitive groups 
and
ㆍpatients with a split-mouth (cross-over) treatment
Primary parameter of the study will be new bone for-
mation (NBF) including the histological assessment. 
Secondary parameters will be volume of the augmentate 
and bone height, see details.
Patient population
Thirty patients will be assessed for the study: Each pa-
tient will be randomly assigned to either comparative or 
test arm. Because of the surgical intervention, neither sur-
geon nor patient can be effectively blinded. 
Step by step surgical procedures
For experienced oral surgeons, allograft bone blocks for 
block augmentation are the only real alternative to har-
vesting patients own autogenic bone blocks, preventing 
well known risks as donor-site morbidity, infection risk, 
pain and loss in bone stability.
As a carrier of our stem cell containing tissues we are 
using a sterile, high-safety (donor selection, virus testing, 
chemical cleaning, processing and sterilization) allograft 
product, derived of human donor bone, processed by the 
Cell+Tissue Bank Austria (CTBA). The high biologic re-
generation capability of allogenic bone blocks results in 
a predictable clinical outcome.
Properties (Fig. 3)
ㆍPreserved biomechanical properties
ㆍSterile without antigenic effects
ㆍStorable at room temperature for 5 years
ㆍOsteoconductive properties supporting natural and 
controlled tissue remodeling.
In the case presented here one allogen bonering was 
used. Until the lateral access to the maxillary sinus is pre-
pared, the allogen bonering is steeped in native blood 
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Fig. 4. X-ray situation after loading and finally clinical result with 
placed implants and superconstruction.
mixed. The bonering was introduced vertically into the 
maxillary sinus. It stabilizes the implant by buttressing 
them. The cortical portion of the rings was aligned cra-
nially since this makes adaptation of the cancellous por-
tion of the ring to the concave-shaped sinus floor much 
easier. The still existing cavity is filled with bone re-
generation material. By screwing in a membrane screw, 
the bone ring is stabilized within the sinus and the im-
plant is anchored in a primary stable position. This proce-
dure enables good results with long-term effects. For har-
vesting the stem cell-containing subepithelial connective 
tissue graft from the palate a horizontal incision to the 
bone will be made 5 mm from the palatal gingival margin 
and the micro-blade will be subsequently placed parallel 
to the long axis of the roots. Another horizontal incision 
will be made 2 mm coronal to the first incision and the 
periosteum will be dissected before removing the wedge 
of soft tissue. An approximately 10×6 mm subepithelial 
connective tissue graft (SCTG) has been harvested from 
the palate in the second premolar to second molar region 
as the source of ecto-mesenchymal stem cells. The SCTG 
trimmed precisely to adapt to the recipient site. X-ray 
shows the situation after loading (Fig. 4) and finally clin-
ical result with placed implants and superconstruction.
In summary this case report confirms that bone re-
generation is possible with PALATAL-DERIVED STEM 
CELLS.
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